Literature DB >> 23668743

Management of the patient with diabetes and coronary artery disease: a contemporary review.

Timothy Raymond1, Russell Raymond, A Michael Lincoff.   

Abstract

Diabetes mellitus is a metabolic disease with microvascular and macrovascular complications, and is well known to increase the risk of coronary atherosclerosis. Despite recent reductions in the prevalence of coronary artery disease and cardiovascular events in the USA, persons with diabetes remain up to four-times as likely to die of cardiovascular disease than the general population. Diabetes is associated with an atherogenic lipid profile, induces a hypercoagulable state, and increases coronary plaque volume, progression and instability. Medicinal and procedural treatments in the patient with diabetes should be multifactorial, targeting and managing the many coexisting risk factors that contribute to atherosclerosis. This type of treatment is complex and should be individualized, and guided by a careful review of recent literature. Here we discuss important clinical data and their impact on up-to-date recommendations for the management of coronary artery disease in the patient with Type 2 diabetes mellitus.

Entities:  

Mesh:

Year:  2013        PMID: 23668743     DOI: 10.2217/fca.13.22

Source DB:  PubMed          Journal:  Future Cardiol        ISSN: 1479-6678


  4 in total

Review 1.  The two faces of miR-29.

Authors:  Anna Ślusarz; Lakshmi Pulakat
Journal:  J Cardiovasc Med (Hagerstown)       Date:  2015-07       Impact factor: 2.160

2.  Vasodilation Responses to Non-Selective α-Adrenergic Blockage of Coronary Bypass Grafts in Diabetic and Non-Diabetic Patients: In Vitro Study.

Authors:  Selami Gurkan; Ozcan Gur; Demet Ozkaramanli Gur; Semil Selcen Gocmez; Turan Ege
Journal:  Ann Thorac Cardiovasc Surg       Date:  2014-09-30       Impact factor: 1.520

3.  Regulation of cardiac expression of the diabetic marker microRNA miR-29.

Authors:  Nicholas Arnold; Purushotham Reddy Koppula; Rukhsana Gul; Christian Luck; Lakshmi Pulakat
Journal:  PLoS One       Date:  2014-07-25       Impact factor: 3.240

4.  Regulation of cardiac miR-208a, an inducer of obesity, by rapamycin and nebivolol.

Authors:  Rukhsana Gul; Abuzar Mahmood; Christian Luck; Kelly Lum-Naihe; Assim A Alfadda; Robert C Speth; Lakshmi Pulakat
Journal:  Obesity (Silver Spring)       Date:  2015-09-18       Impact factor: 5.002

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.